A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

Author: Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.85, Iss.2, 2004-05, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content